Northwest Georgia Oncology Centers, a Service of Wellstar Cobb Hospital-Research ( Site 0028) — Marietta, Georgia

Public research footprint of Northwest Georgia Oncology Centers, a Service of Wellstar Cobb Hospital-Research ( Site 0028), compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Most-studied conditions

Non-small Cell Lung Cancer (NSCLC) · Carcinoma, Renal Cell · Squamous Cell Carcinoma of Head and Neck · Carcinoma, Non-Small-Cell Lung

Recently updated registry entries

NCT06305754 — Sacituzumab Tirumotecan (MK-2870) Versus Pemetrexed and Carboplatin Combination Therapy… (Active Not Recruiting)
NCT06596694 — Study of Patritumab Deruxtecan in Participants With Gastrointestinal Cancers… (Recruiting)
NCT06170788 — Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Northwest Georgia Oncology Centers, a Service of Wellstar Cobb Hospital-Research ( Site 0028)?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.